ストックスクリーナーアプリを入手
24.12
0.50%
0.12
前日終値:
$24.00
開ける：
$24.12
24時間の取引高:
2,825
Relative Volume:
0.10
時価総額：
$N/A
収益：
-
当期純損益:
-
株価収益率:
-
EPS:
-
ネットキャッシュフロー:
-
1週間 パフォーマンス:
-1.95%
1か月 パフォーマンス:
+5.10%
6か月 パフォーマンス:
+20.87%
1年 パフォーマンス:
-15.68%
1日の値動き範囲:
$24.12
$24.31
1週間の範囲:
$23.81
$24.73
52週間の値動き範囲:
$13.42
$31.65
Virtus Lifesci Biotech Clinical Trials Etf Stock (BBC) Company Profile
BBC を他の銘柄と比較する
| 株式 | 価格 | 時価総額 | 収益 | 当期純利益 | 現金流量 | EPS |
|---|---|---|---|---|---|---|
BBC
Virtus Lifesci Biotech Clinical Trials Etf
|
24.12 | 0 | 0 | 0 | 0 | 0.00 |
|
VTI
Vanguard Total Stock Market Etf
|
325.45 | 417.53B | 0 | 0 | 0 | 0.00 |
|
SPY
Spdr S P 500 Etf Trust
|
660.00 | 372.57B | 0 | 0 | 0 | 0.00 |
|
IVV
Ishares Core S P 500 Etf
|
661.30 | 253.41B | 0 | 0 | 0 | 0.00 |
|
VB
Vanguard Small Cap Etf
|
255.34 | 160.59B | 0 | 0 | 0 | 0.00 |
|
QQQ
Invesco Qqq Trust Series 1
|
591.18 | 124.43B | 0 | 0 | 0 | 0.00 |
Virtus Lifesci Biotech Clinical Trials Etf (BBC) 最新ニュース
The Zacks Analyst Blog Highlights BWET, GOEX, SLVP, LIT and BBC - sharewise.com
Best-Performing ETFs of Last Week - sharewise.com
2 High Risk ETFs That Aren’t Leveraged, Inverse, or Single-Stock - Investing.com
XBI: Surprise Exit Of A Tough Regulator At The FDA (NYSEARCA:XBI) - Seeking Alpha
(BBC) Technical Data - news.stocktradersdaily.com
How to Take Advantage of moves in (BBC) - news.stocktradersdaily.com
(BBC) Trading Report - news.stocktradersdaily.com
(BBC) Trading Signals - news.stocktradersdaily.com
Learn to Evaluate (BBC) using the Charts - news.stocktradersdaily.com
Vinay Prasad's Appointment To FDA's CBER Triggers Questions Over Future Of Cell And Gene Therapy Regulation - Benzinga
ETFs Last Week: Funds Lead The Charge As Markets Stage A Return To Risk-On - Benzinga
Tech Rally Boosted Wall Street Last Week: Winning ETFs in Focus - TradingView
6 Best-Performing ETFs of Last Week - TradingView
(BBC) Investment Analysis and Advice - news.stocktradersdaily.com
Wall Street Week Ahead - Seeking Alpha
Trend Tracker for (BBC) - news.stocktradersdaily.com
7 Best-Performing Biotech ETFs for March 2025 - NerdWallet
(BBC) Trading Advice - Stock Traders Daily
5 Top ETFs of Last Week - Yahoo Finance
SBIO, XBI, or BBP: Which is the Best Biotech ETF, According to Analysts? - Nasdaq
Pharma Stocks Look Cheap. Here's One Way to Invest. - Nasdaq
Long Term Trading Analysis for (BBC) - news.stocktradersdaily.com
The 5 Best Biotech ETFs of 2024 - ETF.com
Last Week, Virtus LifeSci Biotech Clinical Trials ETF Climbed 10%. Why? - CMC Markets
This biotech ETF sees ‘breakout’ while U.S. small-cap technology stocks lag - MarketWatch
Top and Flop Industry ETFs of Q3 - Nasdaq
ETFs to Play Biden's 2024 Reelection Campaign Launch - Nasdaq
ALPS’ Biotech ETF SBIO Week’s Top Performer - ETF Trends
Innovation Reigns In 10 Best-Performing ETFs Of The Last 3 Months - FA Mag
Biotech ETFs Advance on Speculation of a Takeover Bid for Global Blood Therapeutics - ETF Trends
5 ETFs Riding High on the Biotech Comeback - Zacks Investment Research
Biotech ETFs Are Making a Comeback - ETF Trends
Best Performing ETFs For June 2022 - TheStreet
Biotech ETF Tops in June: 5 Stocks That Outperform - Zacks Investment Research
Biotech ETFs Strengthen as Bristol Myers Squibb Buys Turning Point - ETF Trends
Betting on Biotech Bear Market Expiration Date - ETF Trends
How to Pick a Biotech ETF - Investment U
Positioning for Biotech Bounceback - ETF Trends
Make Biotech Cash Considerations With SBIO - ETF Trends
Some Biotech Stocks Are Now Cheap - ETF Trends
Biotech ETFs That Outperformed Last Week - Yahoo Finance
ETF Exchange: Latest ETF News & Insights | Pensions & Investments - Pensions & Investments
Size Up SBIO Ahead of Biotech Rebound - ETF Trends
Finding Synergy With SPY - ETF.com
Biotech ETFs Surge on Biogen's Alzheimer Drug Approval - Yahoo Finance
Want to Use ETFs to Play Biotech? Choose Wisely. - Barron's
More than Just COVID: Hot ETFs for Medical Breakthroughs - ETF Trends
Top Tech ETFs Right Now - Benzinga
Biotech ETFs Soar on Gilead-Immunomedics Deal - Yahoo Finance
Betting on Biotech With Utility Beyond Covid-19 - ETF Trends
A Healthcare ETF Could Benefit From Index Reshuffling - ETF Trends
Virtus Lifesci Biotech Clinical Trials Etf (BBC) 財務データ
Virtus Lifesci Biotech Clinical Trials Etf (BBC) の財務データはありません。詳細については、他の銘柄を確認してください。
収益
当期純利益
現金流量
EPS
0.11%
大文字化:
|
ボリューム (24 時間):